16 August 2001 News Update
NZ LEAD OSTEOPOROSIS DEAL
New discoveries by scientists at Auckland University, have resulted in a substantial trans-Tasman licensing agreement to develop a potential world-first treatment for osteoporosis.
The bone-thinning disease is now reaching epidemic proportions, particularly among women and the elderly, says UniServices intellectual property manager, Johanna Stapelberg.
If the development of the new drugs is successful, it could lead to significant royalties to the university.
The new drug appears to be free of side effects, and stops bone loss and promotes bone-cell growth.
Back to welcome page
Back to news archives
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
Click here to find out who the winners are for the Pharmacy Today/Zuellig Pharma Pharmacy Awards 2002. Also view and purchase photos of the Awards.
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
Consumer Health Information
New Zealand Doctor Online
Home II Conferences II Contact Us II Continuing Education II Magazine Profile II Monthly News Archives
Weekly News Archives II II Readership II Search Magazine Archives